MONMOUTH JUNCTION, N.J. (AP) _ CytoSorbents Corp. (CTSO) on Tuesday reported a loss of $9.3 million in its fourth quarter.The Monmouth Junction, New Jersey-based company said it had a loss of 21 cents per share.The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share.The blood purification therapy company posted revenue of $10.8 million in the period, exceeding Street forecasts. Three analysts surveyed by Zacks expected $9.7 million.For the year, the company reported that its loss widened to $24.6 million, or 57 cents per share. Revenue was reported as $43.2 million._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CTSO at https://www.zacks.com/ap/CTSO